Jerry M. Zuckerman

1.1k total citations
11 papers, 485 citations indexed

About

Jerry M. Zuckerman is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Jerry M. Zuckerman has authored 11 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Infectious Diseases and 3 papers in Surgery. Recurrent topics in Jerry M. Zuckerman's work include Pneumonia and Respiratory Infections (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Antibiotic Resistance in Bacteria (3 papers). Jerry M. Zuckerman is often cited by papers focused on Pneumonia and Respiratory Infections (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Antibiotic Resistance in Bacteria (3 papers). Jerry M. Zuckerman collaborates with scholars based in United States. Jerry M. Zuckerman's co-authors include Bartholomew R. Bono, Allan R. Tunkel, Kenneth M. Kaye, Keith S. Kaye, Jane D. Siegel, Thomas R. Talbot, Evelyn Cook, Susan S. Huang and Deverick J. Anderson and has published in prestigious journals such as Infection Control and Hospital Epidemiology, Infectious Disease Clinics of North America and Medical Clinics of North America.

In The Last Decade

Jerry M. Zuckerman

11 papers receiving 458 citations

Peers

Jerry M. Zuckerman
G W Amsden United States
Y Niki Japan
Jun Hirai Japan
MARGARET R. ANDERSON United States
J. A. Faiella United States
Charlene Desbonnet United States
Jürg Blaser Switzerland
J. Mohler France
Jerry M. Zuckerman
Citations per year, relative to Jerry M. Zuckerman Jerry M. Zuckerman (= 1×) peers Mónica Gordón

Countries citing papers authored by Jerry M. Zuckerman

Since Specialization
Citations

This map shows the geographic impact of Jerry M. Zuckerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry M. Zuckerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry M. Zuckerman more than expected).

Fields of papers citing papers by Jerry M. Zuckerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry M. Zuckerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry M. Zuckerman. The network helps show where Jerry M. Zuckerman may publish in the future.

Co-authorship network of co-authors of Jerry M. Zuckerman

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry M. Zuckerman. A scholar is included among the top collaborators of Jerry M. Zuckerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry M. Zuckerman. Jerry M. Zuckerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zuckerman, Jerry M., et al.. (2021). Prevention of Mycobacterium tuberculosis Transmission in Health Care Settings. Infectious Disease Clinics of North America. 35(4). 1013–1025. 10 indexed citations
2.
Zuckerman, Jerry M., et al.. (2016). Preventing Transmission of Mycobacterium tuberculosis in Health Care Settings. Infectious Disease Clinics of North America. 30(4). 1013–1022. 2 indexed citations
3.
Kaye, Keith S., Deverick J. Anderson, Evelyn Cook, et al.. (2015). Guidance for Infection Prevention and Healthcare Epidemiology Programs: Healthcare Epidemiologist Skills and Competencies. Infection Control and Hospital Epidemiology. 36(4). 369–380. 23 indexed citations
4.
Zuckerman, Jerry M., et al.. (2011). Review of Macrolides (Azithromycin, Clarithromycin), Ketolids (Telithromycin) and Glycylcyclines (Tigecycline). Medical Clinics of North America. 95(4). 761–791. 78 indexed citations
5.
Zuckerman, Jerry M.. (2010). Prevention of Health Care–Acquired Pneumonia and Transmission of Mycobacterium tuberculosis in Health Care Settings. Infectious Disease Clinics of North America. 25(1). 117–133. 2 indexed citations
6.
Zuckerman, Jerry M., et al.. (2009). Macrolides, Ketolides, and Glycylcyclines: Azithromycin, Clarithromycin, Telithromycin, Tigecycline. Infectious Disease Clinics of North America. 23(4). 997–1026. 61 indexed citations
7.
Zuckerman, Jerry M.. (2004). Macrolides and ketolides: azithromycin, clarithromycin, telithromycin. Infectious Disease Clinics of North America. 18(3). 621–649. 144 indexed citations
8.
Zuckerman, Jerry M.. (2000). THE NEWER MACROLIDES: AZITHROMYCIN AND CLARITHROMYCIN. Infectious Disease Clinics of North America. 14(2). 449–462. 59 indexed citations
9.
Zuckerman, Jerry M. & Kenneth M. Kaye. (1995). THE NEWER MACROLIDES. Infectious Disease Clinics of North America. 9(3). 731–745. 42 indexed citations
10.
Zuckerman, Jerry M. & Allan R. Tunkel. (1994). Itraconazole: A New Triazole Antifungal Agent. Infection Control and Hospital Epidemiology. 15(6). 397–410. 40 indexed citations
11.
Zuckerman, Jerry M. & Allan R. Tunkel. (1994). Itraconazole: A New Triazole Antifungal Agent. Infection Control and Hospital Epidemiology. 15(6). 397–410. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026